Efficacy of Fluoxetine - a Trial in Stroke "EFFECTS"


Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to investigate whether routine administration of fluoxetine 20mg once daily in the 6 months initiated during the acute stroke improves the patient's functional outcome. EFFECTS is an investigator lead Sweden-based, multicenter, parallel group, double blind placebo controlled trial with broad entry criteria and follow up at 6 and 12 months. The anticipated numbers of...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2017.

20 Oct 2014 2 Feb 2016 1 Jul 2019 1 Jul 2020 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment